BD Max System
BD Max System
BD Max System
BD Max System
BD Max System

BD MAX™ C Difficile

True walkaway automation to improve diagnosis and treatment of Clostridium difficile infections (CDI)

Clostridium difficile infections (CDI) have increased substantially in the last decade and continue to challenge clinicians, epidemiologists, and microbiologists. 15-25% of cases of antibiotic-associated diarrhea and over 95% of cases of antibiotic-associated pseudomembranous colitis are caused by CDIs,resulting in over $1 billion in excess health care costs annually.2

Nucleic acid amplification tests provide better sensitivity over enzyme immunoassay (EIA) and glutamate dehydrogenase (GDH) testing algorithms and are easier to perform compared to toxigenic culture.3,4

The BD MAX™ Cdiff assay delivers accurate and timely results which enable appropriate treatment and infection control measures to be implemented which helps improve patient outcomes, potentially reduce hospital costs, and increase patient satisfaction.5

The BD MAX™ System is a fully automated sample-to-result platform that provides unique versatility, enabling you to consolidate and standardize your molecular testing.

With up to 24 results in < 3 hours, BD MAX™ can be easily integrated into your routine laboratory workflow.

Related Products



Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.

Link

References
  1. Bartlett JG et al, CID 46(Suppl 1):S12-S18.
  2. Dubberke ER, et al, CID 2008;46:497–504.
  3. Cohen SH, et al, ICHE 2010;31:431–55.
  4. Swindells J,et al, J Clin Microbiol 2010;48:606–8.
  5. M. Catanzaro, AJIC January 2012.
  6. Lyras D, et al, Nature 458:1176-9.

This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience.